MPAM
REGN icon

Murphy Pohlad Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Murphy Pohlad Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19M Hold
3,508
– – 0.76% 46
2026
Q1 		$2.71M Hold
3,508
– – 0.97% 41
2025
Q4 		$2.71M Buy
3,508
+75
+2% +$50.9K 1.04% 39
2025
Q3 		$1.93M Buy
3,433
+1,853
+117% +$1.05M 0.76% 48
2025
Q2 		$830K Sell
1,580
-20
-1% -$11.2K 0.35% 72
2025
Q1 		$1.01M Hold
1,600
– – 0.43% 67
2024
Q4 		$1.14M Hold
1,600
– – 0.49% 64
2024
Q3 		$1.68M Sell
1,600
-100
-6% -$111K 0.7% 55
2024
Q2 		$1.79M Sell
1,700
-169
-9% -$164K 0.77% 51
2024
Q1 		$1.8M Sell
1,869
-5
-0.3% -$4.75K 0.7% 53
2023
Q4 		$1.65M Sell
1,874
-1,115
-37% -$918K 0.68% 53
2023
Q3 		$2.46M Sell
2,989
-130
-4% -$102K 1.08% 37
2023
Q2 		$2.24M Sell
3,119
-172
-5% -$133K 0.97% 43
2023
Q1 		$2.7M Sell
3,291
-124
-4% -$93.5K 1.12% 40
2022
Q4 		$2.46M Sell
3,415
-118
-3% -$87.1K 1.01% 43
2022
Q3 		$2.43M Sell
3,533
-100
-3% -$62.9K 1.13% 39
2022
Q2 		$2.15M Sell
3,633
-50
-1% -$32.5K 0.94% 45
2022
Q1 		$2.57M Hold
3,683
– – 1.04% 40
2021
Q4 		$2.33M Sell
3,683
-90
-2% -$55.3K 0.91% 43
2021
Q3 		$2.28M Buy
3,773
+966
+34% +$600K 0.93% 44
2021
Q2 		$1.57M Buy
2,807
+75
+3% +$38K 0.63% 55
2021
Q1 		$1.29M Hold
2,732
– – 0.56% 53
2020
Q4 		$1.32M Hold
2,732
– – 0.65% 51
2020
Q3 		$1.53M Buy
2,732
+105
+4% +$63.7K 0.81% 49
2020
Q2 		$1.64M Buy
2,627
+255
+11% +$145K 0.92% 47
2020
Q1 		$1.16M Buy
+2,372
New +$978K 0.79% 47

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MCI
McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Murphy Pohlad Asset Management's REGN Position: Q2 2026 in Review

Murphy Pohlad Asset Management held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 3,508 shares worth $2.19M. The position accounts for 0.76% of the portfolio, ranked #46.

Murphy Pohlad Asset Management first reported a position in REGN in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.71M in Q1 2026. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Murphy Pohlad Asset Management held 3,508 shares of Regeneron Pharmaceuticals worth $2.19M as of Q2 2026.
  • Murphy Pohlad Asset Management left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.76% of Murphy Pohlad Asset Management's portfolio in Q2 2026, its #46 holding.
  • Murphy Pohlad Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Murphy Pohlad Asset Management's Regeneron Pharmaceuticals position peaked at $2.71M in Q1 2026.
  • 518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Murphy Pohlad Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.